An Open-Label, Observational Study of the Effects of Anti-TNF Therapy on Peripheral Blood and Synovial Biomarkers in Patients with Active Rheumatoid Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Adalimumab; Etanercept
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- Sponsors Roche
- 25 Jul 2011 This trial is recruiting in United Kingdom and has discontinued in Sweden.
- 24 Jul 2011 New trial record